Spruce Biosciences (SPRB) Other Non-Current Assets (2019 - 2026)
Spruce Biosciences' Other Non-Current Assets was $1.18 million in Q2 2026, compared with $64,000 a year earlier and up 118.0% from the prior quarter.
Spruce Biosciences (SPRB) Other Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Assets at Spruce Biosciences came in at $243,000, up 252.2% from FY2024.
- Other Non-Current Assets shows a five-year compound annual growth rate of -12.6% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $69,000 in FY2024 (-88.1%), $582,000 in FY2023 (-9.1%), $640,000 in FY2022 (-2.0%) and $653,000 in FY2021 (+36.9%).
- The Q2 2026 figure marks the highest quarterly Other Non-Current Assets since Q3 2020.
- Compared with a year earlier, Other Non-Current Assets was higher in two of the last seven quarters, with growth averaging 10.9%.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q4 2025 (growth of 252.2%); the worst was Q3 2021 (a decline of 90.8%).
- Per Business Quant data, SPRB's Other Non-Current Assets in the three quarters before Q2 2026 was $539,000 (Q1 2026), $243,000 (Q4 2025) and $62,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Spruce Biosciences | 102.66 Mn | -107.29 Mn | - | 1.18 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 539,000.00 |
| Dec 31, 2025 | 243,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 64,000.00 |
| Mar 31, 2025 | 204,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 531,000.00 |
| Jun 30, 2024 | 547,000.00 |
| Mar 31, 2024 | 553,000.00 |
| Dec 31, 2023 | 582,000.00 |
| Sep 30, 2023 | 607,000.00 |
| Jun 30, 2023 | 536,000.00 |
| Mar 31, 2023 | 525,000.00 |
| Dec 31, 2022 | 640,000.00 |
| Sep 30, 2022 | 883,000.00 |
| Jun 30, 2022 | 890,000.00 |
| Mar 31, 2022 | 894,000.00 |
| Dec 31, 2021 | 653,000.00 |
| Sep 30, 2021 | 216,000.00 |
Spruce Biosciences Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=SPRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "SPRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=SPRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();